https://www.biorxiv.org/content/10.1101/2020.09.11.294363v1
These data underscore the value of mCoV-A59 model to test mechanism and
establishes harnessing of the ketogenic immunometabolic checkpoint as a
potential treatment against COVID-19 in the elderly.
Ryu, S. et al. (2020). Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model. bioRxiv, s. 2020.09.11.294363. doi:10.1101/2020.09.11.294363
